Centralized echocardiogram quality control in a multicenter study of regression of left ventricular hypertrophy in hypertension

Journal of Hypertension

Volumn 16, Issue 4, 1998, Pages 531-535

  Gosse, Philippe ^a   Guez, David ^b,e   Guéret, Pascal ^c   Dubourg, Olivier ^d   Beauchet, Alain ^d   De Cordoüe, Agnès ^b   Barrandon, Sylvie ^b  

^a HÔPITAL SAINT ANDRÉ   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e IRIS Institut de Recherches Internationales Servier   (France)

Author keywords

Angiotensin converting enzyme inhibitor; Diuretics; Echocardiography; Hypertension; Left ventricular hypertrophy; Measurement of left ventricular mass

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; INDAPAMIDE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; VIDEOTAPE;

EID: 0031977843     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816040-00015     Document Type: Article

References (9)

1. Casale PN, Devereux RB, Milner M, Zullog G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
2. Gosse P, Dallochio M. La régression de l'hypertension ventriculaire gauche chez l'hypertendu. Paris: Editions de Médecine Pratique; 1992. p. 181.
3. Devereux RB, Reichek N. Echocardiographic determination of LVM in man: anatomic validation of the method. Circulation 1977; 5:613-618.
4. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; i:307-311.
5. Devereux RB, Agabiti-Rosei E, Dahlöf B, Gosse P, Hahn RT, Okin PM, et al. Regression of left ventricular hypertrophy as surrogate end-point for morbid events in hypertension treatment trials. J Hypertens 1996; 14 (suppl 2):S95-S102.
6. Devereux RB, Dahlof B, Levy D, Pfeffer MA. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol 1996; 78:61-65.
7. Dahlöf B, Devereux R, de Faire U, Fyhrquist F, Hedner T, Ibsen H, et al. Losartan intervention for endpoint reduction in hypertension (the LIFE study). Am J Hypertens 1997; 10:705-713.
8. Gottdiener JS, Livengood SV, Meyer PS, Chase GA. Should echocardiography be performed to assess effects of antihypertensive therapy? Test-retest reliability of echocardiography for measurement of left ventricular mass and function. J Am Coll Cardiol 1995; 2:424-430.
9. Abergel E, Tase M, Bohlender J, Menard J, Chatellier G. Which definition for echocardiographic left ventricular hypertrophy? Am J Cardiol 1995; 75:498-502.